IO Biotech Inc
IOBT2.080USD
-0.140-6.31%
交易中 （美東）報價延遲15分鐘
137.03M總市值
虧損本益比TTM
關於 IO Biotech Inc 公司
IO Biotech Inc 是一家臨牀階段的生物製藥公司，基於 T-win 技術平臺開發免疫調節癌症療法。該公司的候選產品旨在誘導免疫系統同時靶向和破壞調節腫瘤誘導免疫抑制的多種途徑。IO Biotech 的主要候選產品 IO102-IO103 旨在靶向由 IDO 和 PD-L1 等關鍵免疫抑制蛋白介導的免疫抑制機制。該公司開發了一系列候選產品，利用其 T-win 技術平臺來解決 TME 內的目標。該公司是丹麥赫爾勒夫大學醫院國家癌症免疫治療中心的子公司。
公司簡介
公司代碼IOBT
公司名稱IO Biotech Inc
上市日期Nov 05, 2021
CEODr. Mai-Britt Zocca, Ph.D.
員工數量80
證券類型Ordinary Share
年結日Nov 05
公司地址Ole Maaloes Veh 3
城市COPENHAGEN
上市交易所NASDAQ Global Select Consolidated
國家Denmark
郵編2200
電話4570702980
網址https://www.iobiotech.com/
公司代碼IOBT
上市日期Nov 05, 2021
CEODr. Mai-Britt Zocca, Ph.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Mai-Britt Zocca, Ph.D.
Dr. Mai-Britt Zocca, Ph.D.
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
76.47K
--
Mr. Devin Whittemore Smith
Mr. Devin Whittemore Smith
General Counsel, Company Secretary
General Counsel, Company Secretary
16.93K
+243.31%
Ms. Heidi Hunter
Ms. Heidi Hunter
Independent Director
Independent Director
15.00K
--
Mr. Brian Burkavage
Mr. Brian Burkavage
Chief Accounting Officer, Vice President - Finance
Chief Accounting Officer, Vice President - Finance
11.50K
+666.67%
Dr. Helen Louise Collins, M.D.
Dr. Helen Louise Collins, M.D.
Director
Director
--
--
Ms. Kathleen Sereda Glaub
Ms. Kathleen Sereda Glaub
Independent Director
Independent Director
--
--
Dr. Christian E. Elling, Ph.D.
Dr. Christian E. Elling, Ph.D.
Independent Director
Independent Director
--
--
Dr. Peter Hirth, Ph.D.
Dr. Peter Hirth, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Mr. David V. Smith
Mr. David V. Smith
Independent Director
Independent Director
--
--
Dr. Faical Miyara, Ph.D.
Dr. Faical Miyara, Ph.D.
Chief Business Officer
Chief Business Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Mai-Britt Zocca, Ph.D.
Dr. Mai-Britt Zocca, Ph.D.
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
76.47K
--
Mr. Devin Whittemore Smith
Mr. Devin Whittemore Smith
General Counsel, Company Secretary
General Counsel, Company Secretary
16.93K
+243.31%
Ms. Heidi Hunter
Ms. Heidi Hunter
Independent Director
Independent Director
15.00K
--
Mr. Brian Burkavage
Mr. Brian Burkavage
Chief Accounting Officer, Vice President - Finance
Chief Accounting Officer, Vice President - Finance
11.50K
+666.67%
Dr. Helen Louise Collins, M.D.
Dr. Helen Louise Collins, M.D.
Director
Director
--
--
Ms. Kathleen Sereda Glaub
Ms. Kathleen Sereda Glaub
Independent Director
Independent Director
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月22日 週四
更新時間: 5月22日 週四
持股股東
股東類型
持股股東
持股股東
佔比
Lundbeckfond Ventures
21.18%
Kurma Partners SA
10.35%
Vivo Capital, LLC
9.37%
HBM Partners AG
5.99%
Novo Holdings A/S
5.09%
Other
48.02%
持股股東
持股股東
佔比
Lundbeckfond Ventures
21.18%
Kurma Partners SA
10.35%
Vivo Capital, LLC
9.37%
HBM Partners AG
5.99%
Novo Holdings A/S
5.09%
Other
48.02%
股東類型
持股股東
佔比
Venture Capital
47.38%
Investment Advisor
8.35%
Hedge Fund
4.71%
Investment Advisor/Hedge Fund
3.44%
Research Firm
2.54%
Individual Investor
0.36%
Other
33.21%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
52
44.00M
66.79%
-12.23M
2025Q1
56
44.00M
66.79%
+640.94K
2024Q4
57
44.61M
67.71%
+1.88M
2024Q3
50
48.46M
73.56%
+5.16M
2024Q2
48
51.73M
78.53%
+7.90M
2024Q1
53
52.99M
80.43%
+6.73M
2023Q4
55
54.27M
82.38%
+8.45M
2023Q3
56
56.33M
89.04%
+20.70M
2023Q2
46
22.57M
78.34%
-5.75M
2023Q1
42
24.23M
84.91%
+7.02M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Lundbeckfond Ventures
13.95M
21.18%
--
--
Apr 11, 2025
Kurma Partners SA
6.82M
10.35%
--
--
Apr 11, 2025
Vivo Capital, LLC
6.17M
9.37%
--
--
Apr 11, 2025
HBM Partners AG
3.94M
5.99%
--
--
Apr 11, 2025
Novo Holdings A/S
3.35M
5.09%
--
--
Mar 31, 2025
PFM Health Sciences, LP
2.34M
3.55%
--
--
Mar 31, 2025
Marshall Wace LLP
2.11M
3.2%
--
--
Mar 31, 2025
BofA Global Research (US)
1.65M
2.51%
--
--
Mar 31, 2025
Pivotal Bioventure Partners Investment Advisor LLC
864.20K
1.31%
--
--
Mar 31, 2025
Morgan Stanley Smith Barney LLC
789.46K
1.2%
-69.71K
-8.11%
Mar 31, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
